Loading institutional data...
Loading institutional data...
Held by 290 of 5,944 reporting institutions (94th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Ranked against 235 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WMT | $896.8B | 41.1× | — | 1.3× | 4.7% | 24.9% | 3.1% | 22.0% | 15.5% | — | 4,273 |
| COST | $417.5B | 51.7× | 31.9× | 1.5× | 8.2% | 12.8% | 2.9% | 27.8% | 23.2% | 0.4× | 4,050 |
| KO | $373.6B | 28.6× | 24.5× | 7.8× | 1.9% | 61.6% | 27.3% | 40.7% | 40.7% | — | 3,427 |
| PG | $345.0B | 22.6× | 16.3× | 4.1× | 0.3% | 51.2% | 19.0% | 30.6% | 18.4% | 1.5× | 3,849 |
| PM | $294.0B | 26.0× | 17.1× | 7.2× | 7.3% | 67.1% | 27.9% | -114% | -115% | 0.0× | 2,744 |
| PEP | $190.0B | 23.1× | 15.4× | 2.0× | 2.3% | 54.1% | 8.8% | 40.4% | 11.8% | 3.3× | 3,404 |
| BUDFF | $151.5B | — | — | — | — | — | — | — | — | — | 5 |
| UNLYF | $138.7B | — | — | — | — | — | — | — | — | — | 23 |
| MO | $114.6B | 16.6× | 13.2× | 4.9× | -3.1% | 62.5% | 29.8% | -198% | 33.7% | 2.4× | 2,375 |
| MNST | $92.4B | — | 35.6× | 11.1× | 10.7% | 55.8% | 23.0% | 23.1% | 23.1% | — | 1,169 |
| MDLZ | $81.0B | 33.1× | 19.0× | 2.1× | 5.8% | 28.4% | 6.4% | 9.5% | 8.6% | 0.6× | 1,821 |
| CL | $74.7B | 35.5× | 20.4× | 3.7× | 1.4% | 60.1% | 10.5% | 3948% | 30.8% | 1.7× | 1,873 |
| TGT | $66.9B | 18.2× | 9.8× | 0.6× | -1.7% | 27.9% | 3.5% | 22.9% | 12.1% | 1.7× | 1,771 |
| DGEAF | $54.3B | — | — | — | — | — | — | — | — | — | 4 |
| CCEP | $48.8B | — | — | — | — | — | — | — | — | — | 543 |
| ABEV | $47.8B | — | — | — | — | — | — | — | — | — | 383 |
| JBS | $45.1B | — | — | — | — | — | — | — | — | — | 241 |
| FMX | $42.4B | — | — | — | — | — | — | — | — | — | 290 |
| KDP | $41.8B | 20.1× | 14.1× | 2.5× | 8.2% | 54.2% | 12.5% | 8.1% | 5.0% | 4.0× | 784 |
| SYY | $41.1B | 22.6× | 10.3× | 0.5× | 3.2% | 18.4% | 2.2% | 99.9% | 99.9% | — | 1,489 |
| KVUE | $37.7B | 25.9× | 15.7× | 2.5× | -2.1% | 58.1% | 9.7% | 13.7% | 7.1% | 3.4× | 967 |
| ADM | $37.6B | 34.8× | — | 0.5× | -6.2% | 6.3% | 1.3% | 4.7% | 3.6% | — | 1,070 |
| KMB | $37.3B | 18.5× | 11.8× | 2.3× | -2.1% | 36.0% | 12.3% | 135% | 92.0% | 0.2× | 1,585 |
| KR | $37.0B | 36.8× | 9.2× | 0.3× | 0.4% | — | 0.7% | 17.1% | 5.0% | 2.8× | 1,327 |
| HSY | $36.4B | — | 21.2× | 3.1× | 4.4% | 33.5% | 7.6% | 19.0% | 9.3% | 2.5× | 1,406 |
Peers = companies sharing FMX's sector (Consumer Defensive) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
How much the company owes, how it's trended, and how comfortably it's serviced.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest expense isn't separately reported — often netted into “other income (expense), net.”
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
EOD close · as of 2026-08-05 · 15d old
How a revenue dollar becomes profit — FY2024
Each value shows its share of revenue below it (common-size).
| Line Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | $22.06B | $423.19B | $355.49B | $299.28B | $303.31B | $315.23B | $294.57B | $277.84B | $251.30B | $188.41B |
| Gross Profit | $15.42B | $279.51B | $241.52B | $206.18B | $189.65B | $191.48B | $175.17B | $162.09B | $148.20B | $123.18B |
| Interest Expense | $959.0M | $14.92B | $15.85B | $16.63B | $17.52B | $14.13B | $9.82B | $11.09B | $9.65B | $7.78B |
| Net Income | $1.93B | $76.68B | $34.74B | $37.68B | $3.76B | $28.05B | $33.08B | $37.21B | $27.18B | $23.28B |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company doesn't have positive free cash flow, so a reverse DCF can't be run.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
1/2 of the 9 checks — 7 couldn't be scored (see above), so the score is out of the 2 with data.
Insufficient balance-sheet detail (needs retained earnings, working capital, equity).
Needs granular two-year detail (receivables, PP&E, D&A, SG&A) — not fully reported.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-08-05
No standout strengths flagged.
Nothing notable to watch.
No material risks flagged.
Is the profit real, and how strong is the balance sheet?
FY2024 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Operating leverage needs meaningful revenue change.
Each line as % of revenue — the trend in color
| % of revenue | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on FMX: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.